The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has announced that its management team will participate in two upcoming healthcare investor conferences in March 2026. The company is scheduled to present at the TD Cowen 46th Annual Health Care Conference on March 4, 2026. Following this, Regeneron will attend the Leerink Partners 2026 Global Healthcare Conference on March 11, 2026. These appearances are part of the company's routine investor relations engagement to maintain open communication with the financial community. Live webcasts of the presentations will be accessible through the company’s investor relations website, with archived replays remaining available for 30 days following the live events.